OM1
Overview
Real-world data and AI technology company operating the OM1 Real-World Data Cloud with over 300 million patients and deep specialty registries in chronic conditions such as rheumatology, dermatology, cardiology, and behavioral health. Provides outcomes research, AI-derived phenotyping (PhenOM), and evidence generation for life sciences.
Notable
Founded by Dr. Richard Gliklich (former Outcome Sciences CEO); raised an $85M financing round in 2021; partners with medical societies, payers, and manufacturers.
Key services
- specialty condition registries and datasets
- linked clinical and claims RWD
- AI phenotyping and predictive models
- regulatory and HEOR evidence services
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of OM1? Share your experience in a short, confidential interview.
Share your experience